Trend analysis of pediatric urolithiasis prevalence from 1990 to 2021 in the BRICS

Zhi-Gang Zhang1, Qing-Cheng Lin2, Qing-Ying Zhou1

  • 1Department of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.

PubMed

Insights

Pediatric urolithiasis prevalence is rising globally, particularly in India and Russia. While China shows progress, Brazil faces rapid deterioration, highlighting the need for targeted prevention strategies in BRICS nations.

Area of Science:

  • Pediatric Nephrology
  • Public Health
  • Epidemiology

Background:

  • Pediatric urolithiasis (kidney stones in children) shows an increasing epidemiological trend globally.
  • Analysis in Brazil, Russia, India, China, and South Africa (BRICS) is crucial due to their large populations and limited health resources.
  • Understanding these trends informs global public health policy development.

Purpose of the Study:

  • To investigate the prevalence trends of pediatric urolithiasis in BRICS countries from 1990 to 2021.
  • To provide valuable data for prevention and treatment strategies in these nations and worldwide.
  • To analyze disease burden and identify at-risk populations.

Main Methods:

  • Utilized data from the Global Burden of Disease (GBD) database.
  • Employed Joinpoint regression and Auto-Regressive Integrated Moving Average (ARIMA) models for trend analysis.
  • Conducted subgroup analysis to assess age-specific prevalence and geographical variations.

Main Results:

  • Global pediatric urolithiasis prevalence is increasing, especially in the 10-14 age group.
  • India and Russia exhibit the highest disease burden; Russia has the highest Age-Standardized Prevalence Rate (ASPR).
  • Brazil shows the fastest deteriorating trend, South Africa has deficits in the 0-4 age group, and China demonstrates significant progress.

Conclusions:

  • The study provides an in-depth analysis of pediatric urolithiasis burden in BRICS countries using GBD 2021 data.
  • Findings offer insights for policymakers and healthcare providers on prevalence trends and statistical evaluations.
  • BRICS nations must develop targeted prevention and tailored treatment strategies for at-risk populations, aligning with global health evidence.
Abstract